Oncology Nursing Drug Handbook | Mobile App


Oncology Nursing Drug Handbook

4.94(4.9)

Author(s):

Publisher: Jones and Bartlett Publishers, Inc.



Description At A Glance

Written especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

Created especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation.

Key Features

  • Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
  • Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies
  • Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
  • Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
  • New drugs include: avelumab (Bavencio), brigatinib (Alunbrig), durvalumab (Imfinzi), enasidenib (Idhifa), metronidazole hydrochloride (Flagyl), midostaurin (Rydapt), neratinib (Nerlynx), niraparib (Zejula), olaratumab (Lartruvo), ribociclib (Kisqali), rituximab and hyaluronidase human injection (Rituxan Hycela injection), rucaparib (Rubraca), telotristat ethyl (Xermelo), and tisagenlecleucel (Kymriah).
{oncondh18:3259}

Your Voice

By NA
Finally I was able to resolve the issue. Thanks so much for your assistance. I appreciated the emails and the help in getting the issue fixed.

Share Via

KEEP IN TOUCH

     

Subscribe

Copyright © 2019. All rights reserved. Skyscape® is the registered trademark of Skyscape Medpresso, Inc.
All other trademarks, service marks and registrations are the intellectual properties of their respective owners.